167 related articles for article (PubMed ID: 11277408)
1. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
3. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Burnet NG; Coleman N
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):455-66. PubMed ID: 16150117
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
9. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
10. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
Kirkegaard LJ; DeRose PB; Yao B; Cohen C
Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.
Allan K; Jordan RC; Ang LC; Taylor M; Young B
Arch Pathol Lab Med; 2000 Feb; 124(2):216-20. PubMed ID: 10656729
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 in astrocytic tumours: an immunohistochemical study.
Chakrabarty A; Bridges LR; Gray S
Neuropathol Appl Neurobiol; 1996 Aug; 22(4):311-6. PubMed ID: 8875465
[TBL] [Abstract][Full Text] [Related]
15. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
16. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
17. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.
Ho DM; Wong TT; Hsu CY; Ting LT; Chiang H
Cancer; 1998 Jun; 82(12):2459-66. PubMed ID: 9635540
[TBL] [Abstract][Full Text] [Related]
18. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
19. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
20. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]